Tokyo, Japan

Chiharu Ikeda

This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 1993-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiharu Ikeda. Retrieved from https://idiyas.com/inventor/chiharu-ikeda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chiharu Ikeda: Innovator in Antibiotic Production

Introduction

Chiharu Ikeda is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of antibiotic production, particularly through his innovative fermentation processes. With a total of 2 patents, Ikeda's work has garnered attention in the pharmaceutical industry.

Latest Patents

Ikeda's latest patents focus on the production of pradimicin antibiotics. The first patent details a fermentation process for producing BMY-28960 and desxylosyl BMY-28960. It also introduces a novel BMY-28960-producing organism belonging to the genus Actinomadura, designated as strain AB 1236 (ATCC 55208). This innovative approach has the potential to enhance the efficiency of antibiotic production.

Career Highlights

Chiharu Ikeda is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work there has been instrumental in advancing antibiotic research and development. His contributions have not only improved production methods but also expanded the understanding of antibiotic efficacy.

Collaborations

Ikeda has collaborated with several esteemed colleagues, including Tamotsu Furumai and Masami Hatori. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of antibiotic research.

Conclusion

Chiharu Ikeda's contributions to antibiotic production through his innovative patents and collaborations highlight his importance in the pharmaceutical industry. His work continues to pave the way for advancements in antibiotic therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…